Mycobacterium tuberculosis-associated synthetic mycolates differentially exert immune stimulatory adjuvant activity

European Journal of Immunology

Volumn 46, Issue 9, 2016, Pages 2149-2154

  Smet, Muriel ^a   Pollard, Charlotte ^a   De Beuckelaer, Ans ^a   Van Hoecke, Lien ^a,b   Vander Beken, Seppe ^a   De Koker, Stefaan ^a   Al Dulayymi, Juma'a R ^c   Huygen, Kris ^d   Verschoor, Jan ^e   Baird, Mark S ^c   Grooten, Johan ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c BANGOR UNIVERSITY   (United Kingdom)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^e UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Adjuvant biolipids; Mycobacterium tuberculosis; Mycolic acid; T cell responses

Indexed keywords

CYCLOPROPANE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; LIPOSOME; MYCOLIC ACID; OVALBUMIN; PHOSPHATIDYLCHOLINE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CHEMICAL STRUCTURE; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; FEMALE; HYDROPHOBICITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VIVO STUDY; INNATE IMMUNITY; LUNG ALVEOLUS CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; STEREOCHEMISTRY; TH1 CELL; TH17 CELL; VACCINATION;

EID: 84985918599     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646357     Document Type: Article

References (19)

1. Verschoor, J. A., Baird, M. S., Grooten, J., Towards understanding the functional diversity of cell wall mycolic acids of Mycobacterium tuberculosis. Prog. Lipid Res. 2012. 51: 325–339.
2. Watanabe, M., Aoyagi, Y., Ridell, M., Minnikin, D. E., Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 2001. 147: 1825–1837.
3. Al Dulayymi, J. R., Baird, M. S., Roberts, E., The synthesis of single enantiomers of a meromycolic acid. Tetrahedron Lett. 2000. 41: 7107–7110.
4. Al Dulayymi, J. R., Baird, M. S., Roberts, E., Deysel, M., Verschoor, J., The first syntheses of single enantiomers of the major methoxymycolic acid of Mycobacterium tuberculosis. Tetrahedron 2007. 63: 2571–2592.
5. Al Dulayymi, J. R., Baird, M. S., Roberts, E., The synthesis of a single enantiomer of a major α-mycolic acid of Mycobacterium tuberculosis. Tetrahedron 2003. 61: 11939–11951.
6. Koza, G., Baird, M. S., The first synthesis of single enantiomers of ketomycolic acids. Tetrahedron Lett. 2007. 48: 2165–2169.
7. Koza, G., Theunissen, C., Al Dulayymi, J. R., Baird, M. S., The synthesis of single enantiomers of mycobacterial ketomycolic acids containing cis-cyclopropanes. Tetrahedron 2009. 65: 10214–10229.
8. Vander Beken, S., Al Dulayymi, J. R., Naessens, T., Koza, G., Maza-Iglesias, M., Rowles, R., Theunissen, C. et al., Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Eur. J. Immunol. 2011. 41: 450–460.
9. Montamat-Sicotte, D. J., Millington, K. A., Willcox, C. R., Hingley-Wilson, S., Hackforth, S., Innes, J., Kon, O. M. et al., A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J. Clin. Invest. 2011. 121: 2493–2503.
10. Pan, J., Fujiwara, N., Oka, S., Maekura, R., Ogura, T., Yano, I., Anti-cord factor (trehalose 6,6′dimycolate) IgG antibody in tuberculosis patients recognizes mycolic acid subclasses. Microbiol. Immunol. 1999. 43: 863–869.
11. Reed, S. G., Orr, M. T., Fox, C. B., Key roles of adjuvants in modern vaccines. Nat. Med. 2013. 19: 1597–1608.
12. Gopal, R., Monin, L., Slight, S., Uche, U., Blanchard, E., Fallert Junecko, B. A., Ramos-Payan, R. et al., Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog. 2014. 10: e1004099.
13. Khader, S. A., Gopal, R., IL-17 in protective immunity to intracellular pathogens. Virulence 2010. 1: 423–427.
14. Gopal, R., Khader, S. A., Vaccines against tuberculosis: moving forward with new concepts. Expert Rev. Vaccines 2013. 12: 829–831.
15. Kaufmann, S. H., How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 2001. 1: 20–30.
16. Ottenhoff, T. H., Kaufmann, S. H., Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 2012. 8: e1002607.
17. Schoenborn, J. R., Wilson, C. B., Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007. 96: 41–101.
18. Korf, J., Stoltz, A., Verschoor, J., De Baetselier, P., Grooten, J., The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur. J. Immunol. 2005. 35: 890–900.
19. Korf, J. E., Pynaert, G., Tournoy, K., Boonefaes, T., Van Oosterhout, A., Ginneberge, D., Haegeman, A. et al., Macrophage reprogramming by mycolic acid promotes a tolerogenic response in experimental asthma. Am. J. Respir. Crit. Care Med. 2006. 174: 152–160.